Skip to content
HowShorted

SOLENO THERAPEUTICS INC short interest in 2024

In 2024, SOLENO THERAPEUTICS INC's disclosed short interest ran from 4.59% of shares outstanding on 12 Jan 2024 to 10.65% on 31 Dec 2024, a change of +6.06 percentage points. The year's high was 14.69% on 15 Oct 2024 and its low 4.59% on 12 Jan 2024, averaging 9.99% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.91 days on 31 Jul 2024. Full history: SOLENO THERAPEUTICS INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for SOLENO THERAPEUTICS INC in 2024

2024 in figures

Start of year
4.59% (12 Jan 2024)
End of year
10.65% (31 Dec 2024)
Change
+6.06 pp
High
14.69% (15 Oct 2024)
Low
4.59% (12 Jan 2024)
Average
9.99%
Highest days to cover
12.91 (31 Jul 2024)
SEC filings marked
8

Every report in 2024

SOLENO THERAPEUTICS INC short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20244.59%4.45
31 Jan 20244.97%8.37
15 Feb 20244.96%5.48
29 Feb 20245.50%9.01
15 Mar 20247.10%4.4510-K filed, results (8-K)
28 Mar 20248.50%8.17
15 Apr 20249.56%11.70
30 Apr 202410.52%5.64
15 May 20249.80%6.2610-Q filed, results (8-K)
31 May 202410.48%10.15
14 Jun 202410.34%10.63
28 Jun 202410.82%3.56
15 Jul 202412.31%9.35
31 Jul 202412.20%12.91
15 Aug 202410.22%10.1310-Q filed, results (8-K)
30 Aug 202411.55%5.94
13 Sep 202412.00%11.59
30 Sep 202412.76%9.41
15 Oct 202414.69%5.89
31 Oct 202414.31%10.95
15 Nov 202411.00%9.5610-Q filed, results (8-K)
29 Nov 202410.57%6.12
13 Dec 202410.27%6.48
31 Dec 202410.65%7.10

See also: SOLENO THERAPEUTICS INC's full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.